LON:OBD Oxford Biodynamics Share Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Oxford Biodynamics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 104.50 +7.50 (+7.73 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range 95.44Now: GBX 104.50▼ 106.9050-Day Range 73MA: GBX 84.76▼ 9752-Week Range 47Now: GBX 104.50▼ 149.55Volume71,402 shsAverage Volume149,716 shsMarket Capitalization£96.72 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlines Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with Holos Life Sciences Pte. Ltd. to develop non-invasive epigenetic biomarkers associated with sports-related concussions; and Casa Sollievo della Sofferenza to identify EpiSwitch biomarkers for the blood-based diagnosis of Autism Spectrum Disorder. The company was founded in 2007 and is headquartered in Oxford, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Oxford Biodynamics. Previous Next 2.4 Community Rank Outperform VotesOxford Biodynamics has received 102 “outperform” votes. (Add your “outperform” vote.)Underperform VotesOxford Biodynamics has received 110 “underperform” votes. (Add your “underperform” vote.)Community SentimentOxford Biodynamics has received 51.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Oxford Biodynamics and other stocks. Vote “Outperform” if you believe OBD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OBD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldOxford Biodynamics does not currently pay a dividend.Dividend GrowthOxford Biodynamics does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oxford Biodynamics insiders have bought more of their company's stock than they have sold. Specifically, they have bought £44,700 in company stock and sold GBX 0 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Oxford Biodynamics is -27.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oxford Biodynamics is -27.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOxford Biodynamics has a P/B Ratio of 6.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.08 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:OBD Previous Symbol CUSIPN/A CIKN/A Webwww.oxfordbiodynamics.com Phone+44-1865-518910Debt Debt-to-Equity Ratio3.86 Current Ratio11.74 Quick Ratio11.55Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£521,000.00 Price / Sales185.65 Cash FlowGBX 17.27 per share Price / Cash Flow6.05 Book ValueGBX 16.90 per share Price / Book6.18Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees31 Outstanding Shares92,559,800Market Cap£96.72 million Next Earnings DateN/A OptionableNot Optionable GBX 104.50 +7.50 (+7.73 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive OBD News and Ratings via Email Sign-up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter. Oxford Biodynamics (LON:OBD) Frequently Asked Questions How has Oxford Biodynamics' stock price been impacted by Coronavirus (COVID-19)? Oxford Biodynamics' stock was trading at GBX 77.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OBD stock has increased by 34.8% and is now trading at GBX 104.50. View which stocks have been most impacted by COVID-19. How were Oxford Biodynamics' earnings last quarter? Oxford Biodynamics PLC (LON:OBD) released its earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter. View Oxford Biodynamics' earnings history. Who are some of Oxford Biodynamics' key competitors? Some companies that are related to Oxford Biodynamics include Silence Therapeutics (SLN), Neptune Wellness Solutions (NEPT), Ergomed (ERGO), IMV (IMV), ProMetic Life Sciences (PLI), Verona Pharma (VRP), Novacyt (NCYT), Rafael (RFL), Synairgen (SNG), Burcon NutraScience (BU), Tiziana Life Sciences (TILS), Theratechnologies (TH), Medicenna Therapeutics (MDNA), Emblem (EMC) and Fennec Pharmaceuticals (FRX). View all competitors. What other stocks do shareholders of Oxford Biodynamics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford Biodynamics investors own include Oxford BioMedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and GRUPO AVAL ACCI/S (AVAL). Who are Oxford Biodynamics' key executives? Oxford Biodynamics' management team includes the following people: Mr. Christian Gurth Hoyer Millar, CEO & Director (Age 60)Mr. Paul Leslie Stockdale, CFO & Director (Age 44)Dr. Alexandre Akoulitchev, Chief Scientific Officer & Director (Age 57)Mr. Glen A. Ferguson, Pres & Sr. VP of Group's Bus. Devel. of USADr. Aroul Ramadass Ph.D.(CANTAB), PDF (OXON), FCPS, FRAS, Chief Technology Officer What is Oxford Biodynamics' stock symbol? Oxford Biodynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD." How do I buy shares of Oxford Biodynamics? Shares of OBD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Oxford Biodynamics' stock price today? One share of OBD stock can currently be purchased for approximately GBX 104.50. How big of a company is Oxford Biodynamics? Oxford Biodynamics has a market capitalization of £96.72 million and generates £521,000.00 in revenue each year. Oxford Biodynamics employs 31 workers across the globe. What is Oxford Biodynamics' official website? The official website for Oxford Biodynamics is www.oxfordbiodynamics.com. How can I contact Oxford Biodynamics? Oxford Biodynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The biotechnology company can be reached via phone at +44-1865-518910. This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
